JUPITER NEUROSCIENCES INC (JUNS) Financials
$3.10
As on 11-Sep-2026 11:20EDT
Market cap
$4 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
227.7
Div. Yield
0 %
Income Statement ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
0.06
|
0.02
|
--
|
--
|
0.23
|
0.64
|
|||||
|
Cost of Revenue
|
0.01
|
0.00
|
--
|
--
|
--
|
--
|
|||||
|
Gross Profit
|
0.04
|
0.02
|
--
|
--
|
0.23
|
0.64
|
|||||
|
Operating Expenses
|
9.87
|
8.93
|
3.09
|
3.87
|
3.67
|
4.55
|
|||||
|
Operating Profit (EBIT)
|
-9.81
|
-8.91
|
-3.09
|
-3.87
|
-3.43
|
-3.91
|
|||||
|
Other Income
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
-9.20
|
-8.64
|
-2.44
|
-4.78
|
-4.96
|
-4.20
|
|||||
|
Provision for Tax
|
--
|
--
|
--
|
--
|
--
|
0.18
|
|||||
|
Profit after Tax (Net Income)
|
-9.20
|
-8.64
|
-2.44
|
-4.78
|
-4.96
|
-4.38
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
--
|
--
|
--
|
--
|
--
|
--
|
Liabilities ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
-0.37
|
-1.83
|
4.17
|
-5.80
|
-7.14
|
-5.18
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
0.21
|
--
|
0.02
|
0.18
|
0.12
|
0.16
|
|||||
|
Current Liabilities
|
3.88
|
7.40
|
2.01
|
5.77
|
7.26
|
5.68
|
|||||
|
Total Liabilities
|
7.60
|
5.56
|
6.20
|
0.15
|
0.24
|
0.67
|
Assets ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
1.17
|
0.74
|
1.55
|
0.12
|
0.17
|
0.21
|
|||||
|
Current Assets
|
2.55
|
4.82
|
4.65
|
0.03
|
0.07
|
0.45
|
|||||
|
Total Assets
|
7.60
|
5.56
|
6.20
|
0.15
|
0.24
|
0.67
|
|||||
|
Total Debt*
|
1.75
|
5.32
|
0.22
|
2.25
|
1.90
|
0.65
|
|||||
|
Net Current Assets
|
-1.33
|
-2.57
|
2.64
|
-5.74
|
-7.19
|
-5.23
|
Cashflow ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-5.41
|
-3.91
|
-0.48
|
-1.25
|
-1.74
|
|||||
|
Cash Flow from Investing Activities
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash from Financing Activities
|
--
|
5.43
|
7.65
|
0.45
|
0.98
|
1.86
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
Financials Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
-19.11
|
-18.82
|
-6.36
|
-12.10
|
-39.19
|
-37.02
|
|||||
|
Cash EPS ($)
|
--
|
-18.82
|
-6.36
|
-12.10
|
-39.19
|
-37.02
|
|||||
|
Adjusted Book Value ($)
|
--
|
--
|
10.87
|
--
|
--
|
--
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
-11.79
|
-10.19
|
-1.22
|
-9.87
|
-14.67
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
-11.79
|
-10.19
|
-1.22
|
-9.87
|
-14.67
|
Profitability Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-219.49
|
-583.01
|
108.74
|
101.46
|
107.75
|
|||||
|
ROE (%)
|
--
|
-738.83
|
299.46
|
73.91
|
80.47
|
98.54
|
|||||
|
ROA (%)
|
-129.62
|
-146.94
|
-76.83
|
-2,488.03
|
-1,097.63
|
-719.49
|
|||||
|
EBIT Margin (%)
|
--
|
--
|
--
|
--
|
-1,471.38
|
-612.36
|
|||||
|
Net Margin (%)
|
-14,220.12
|
-39,662.77
|
--
|
--
|
-2,125.15
|
-686.39
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
--
|
--
|
--
|
-1.00
|
-0.63
|
-0.43
|
|||||
|
EBIT Growth (%)
|
--
|
--
|
20.14
|
-12.77
|
12.15
|
-111.01
|
|||||
|
Net Profit Growth (%)
|
-55.91
|
-254.35
|
49.00
|
3.51
|
-13.20
|
-164.67
|
|||||
|
EPS Growth (%)
|
-36.87
|
-1.96
|
0.47
|
0.69
|
-0.06
|
-1.65
|
|||||
|
Book Value Growth (%)
|
-121.67
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
-0.05
|
-1.68
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
227.66
|
-0.26
|
0.98
|
--
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
--
|
-0.23
|
-0.25
|
--
|
--
|
--
|
|||||
|
Close Price ($)
|
16.07
|
76.50
|
802.50
|
--
|
--
|
--
|
|||||
|
High Price ($)
|
249.75
|
833.25
|
1,463.25
|
--
|
--
|
--
|
|||||
|
Low Price ($)
|
12.91
|
38.25
|
465.75
|
--
|
--
|
--
|
|||||
|
Market Cap ($ Cr)
|
4.32
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
-2.90
|
0.05
|
-0.39
|
-0.27
|
-0.13
|
|||||
|
Short term debt to equity ratio
|
-4.22
|
-2.90
|
0.05
|
-0.36
|
-0.25
|
-0.09
|
|||||
|
Current Ratio
|
0.66
|
0.65
|
2.31
|
0.00
|
0.01
|
0.08
|
|||||
|
Quick Ratio
|
0.62
|
0.63
|
2.31
|
--
|
--
|
--
|
|||||
|
Interest Coverage
|
-32.71
|
--
|
-12.45
|
-17.70
|
-4.63
|
-34.27
|
Operating Efficiency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
15.83
|
12.10
|
--
|
--
|
--
|
--
|
|||||
|
Asset Turnover
|
0.01
|
0.00
|
--
|
--
|
0.52
|
1.05
|
|||||
|
Receivable days
|
--
|
22.09
|
--
|
--
|
--
|
72.26
|
|||||
|
Inventory Days
|
--
|
6,897.10
|
--
|
--
|
--
|
--
|
|||||
|
Payable days
|
--
|
17,688.68
|
--
|
--
|
--
|
--
|
|||||
|
Cash Conversion Cycle
|
--
|
-10,769.48
|
--
|
--
|
--
|
--
|